183 related articles for article (PubMed ID: 8438480)
1. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
Pearson TC; Hamano K; Morris PJ; Wood KJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
[No Abstract] [Full Text] [Related]
2. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
Hamano K; Morris PJ; Wood KJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
[No Abstract] [Full Text] [Related]
3. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
[No Abstract] [Full Text] [Related]
4. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493
[No Abstract] [Full Text] [Related]
5. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
[No Abstract] [Full Text] [Related]
6. Mechanism of induction of transplantation tolerance using donor antigen and anti-CD4 monoclonal antibody.
Wood KJ; Bushell AR; Darby CR; Pearson TC; West L; Morris PJ
Transplant Proc; 1991 Feb; 23(1 Pt 1):133-4. PubMed ID: 1990498
[No Abstract] [Full Text] [Related]
7. The induction of transplantation tolerance using donor antigen and CD4 monoclonal antibody.
Pearson TC; Madsen JC; Morris PJ; Wood KJ
Transplant Proc; 1990 Aug; 22(4):1955-6. PubMed ID: 2389494
[No Abstract] [Full Text] [Related]
8. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
Chen Z; Cobbold S; Waldmann H; Metcalfe S
Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
[No Abstract] [Full Text] [Related]
9. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
Lowry RP; Konieczny B; Alexander D; Larsen C; Pearson T; Smith S; Narula S
Transplant Proc; 1995 Feb; 27(1):392-4. PubMed ID: 7879034
[No Abstract] [Full Text] [Related]
10. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
11. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
12. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness.
Saitovitch D; Bushell AR; Morris PJ; Wood KJ
Transplant Proc; 1995 Feb; 27(1):117-8. PubMed ID: 7878834
[No Abstract] [Full Text] [Related]
13. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
[No Abstract] [Full Text] [Related]
14. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
[No Abstract] [Full Text] [Related]
15. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
[No Abstract] [Full Text] [Related]
16. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma.
Hancock W; Mottram PL; Purcell LJ; Han WR; Pietersz GA; McKenzie IF
Transplant Proc; 1993 Oct; 25(5):2937-8. PubMed ID: 8212290
[No Abstract] [Full Text] [Related]
17. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression.
Saitovitch D; Morris PJ; Wood KJ
Transplant Proc; 1995 Feb; 27(1):119-20. PubMed ID: 7878844
[No Abstract] [Full Text] [Related]
18. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
19. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
Wang J; Zhang L; Tang J; Jiang S; Wang X
Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]